UPDATE OF REPORT “OUT OF THE DARK: MEETING THE NEEDS OF CHILDREN WITH TUBERCULOSIS” NOVEMBER 2012 This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting th

First Page		Document Content
Date: 2013-06-26 11:30:47 Microbiology Tuberculosis treatment Isoniazid Multi-drug-resistant tuberculosis Pyrazinamide Aeras World Tuberculosis Day Bacillus Calmette-Guérin GeneXpert MTB/RIF Tuberculosis Medicine Health		UPDATE OF REPORT “OUT OF THE DARK: MEETING THE NEEDS OF CHILDREN WITH TUBERCULOSIS” NOVEMBER 2012 This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting th Add to Reading List Source URL: www.lekari-bez-hranic.cz Download Document from Source Website File Size: 191,60 KB Share Document on Facebook

	For immediate release March 21, 2017 Infectex Announces Positive Phase 2b-3 Clinical Trial Results of SQ109 for the Treatment of Multidrug-Resistant Pulmonary Tuberculosis Moscow, Russia and Rockville, MD, USA -- Infecte DocID: 1vkmw - View Document
	PRESS RELEASE Adequate treatment essential to stop TB across Europe – new ECDC/WHO report Stockholm/Copenhagen, 19 MarchOverpatients are estimated to fall sick with tuberculosis (TB) every day across Euro DocID: 1saSR - View Document
	JOINT PRESS RELEASE New ECDC-WHO report: tuberculosis on the retreat in Europe. Concerns about drugresistant TB and treatment failure. Stockholm/Copenhagen, 19 March 2012 DocID: 1rHnT - View Document
	15 \| P a g e Multiple healthcare Seeking behaviors of new Smear positive pulmonary tuberculosis patients attending a diagnosis and treatment center of Bafoussam- Cameroon ABSTRACT FABRICE NEMBOT DJOUMA , ARMELLE VIVIAN DocID: 1qzgC - View Document
	Embargoed: 12 May – 1130 hrs CEST WORLD HEALTH ORGANIZATION RECOMMENDS SHORTENED NINE-MONTH TREATMENT REGIMEN FOR MDR-TB PATIENTS DocID: 1q2l5 - View Document